Crown Wealth Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$452K Buy
1,072
+37
+4% +$14.7K 0.11% 87
2026
Q2
$375K Buy
1,035
+27
+3% +$9.24K 0.1% 93
2026
Q1
$355K Buy
1,008
+27
+3% +$9.6K 0.1% 92
2025
Q4
$321K Buy
981
+71
+8% +$22.5K 0.09% 91
2025
Q3
$257K Buy
910
+35
+4% +$10.2K 0.08% 100
2025
Q2
$244K Buy
875
+26
+3% +$7.37K 0.09% 95
2025
Q1
$265K Buy
849
+45
+6% +$13.3K 0.14% 77
2024
Q4
$210K Sell
804
-38
-5% -$11.3K 0.09% 107
2024
Q3
$271K Buy
842
+2
+0.2% +$654 0.12% 91
2024
Q2
$262K Buy
840
+11
+1% +$3.23K 0.13% 85
2024
Q1
$236K Buy
829
+45
+6% +$13.2K 0.12% 90
2023
Q4
$226K Buy
+784
New +$214K 0.14% 82

Other funds holding AMGN

Crown Wealth Group's AMGN Position: Q3 2026 in Review

Crown Wealth Group increased its Amgen (AMGN) stake by 3.6% in Q3 2026, buying an estimated $14.7K and bringing the position to 1,072 shares worth $452K. The position accounts for 0.11% of the portfolio, ranked #87.

Crown Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 12 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Crown Wealth Group held 1,072 shares of Amgen worth $452K as of Q3 2026.
  • Crown Wealth Group bought 37 Amgen shares in Q3 2026, an estimated $14.7K.
  • Amgen made up 0.11% of Crown Wealth Group's portfolio in Q3 2026, its #87 holding.
  • Crown Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 12 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Crown Wealth Group's 13F filing for Q3 2026, filed 19 Oct 2026.